Neurotoxic Effects of Gadopentetate Dimeglumine: Behavioral Disturbance and Morphology after Intracerebroventricular Injection in Rats—Gd induces brain lesions, MS patients beware (1996).

Authors: D. E. Ray, J. B. Cavanagh, C. C. Nolan, and S. C. R. Williams

Article link: https://www.ajnr.org/content/17/2/365

CONCLUSION Intraventricular administration of contrast medium allows toxicity to be evaluated in areas such as the spinal cord that are not accessible by osmotic opening. While it is unlikely that these toxic effects would be seen at the doses used for clinical imaging by the intravenous route, gadopentetate dimeglumine clearly has some neurotoxic and neuropathologic potential. Although the acute excitation could be attributed to a transiently high local concentration of the agent at the injection site, the lesions were widely distributed through the brain and spinal cord and may reflect a region-specific neurotoxic action, possibly related to central pontine myelinolysis.

Previous
Previous

Gadolinium-Containing Contrast Agent Promotes Multiple Myeloma Cell Growth: Implication for Clinical Use of MRI in Myeloma (2009).

Next
Next

TOXICOLOGICAL AND PHARMACOLOGICAL EFFECTS OFGADOLINIUM- AND SAMARIUM CHLORIDES (1961).